Faculty of Health and Medicine, University of Newcastle, Level 3 East, HMRI Building, Lookout Road, New Lambton Heights 2305, Australia.
Australian Gastrointestinal Research Alliance (AGIRA), Newcastle 2305, Australia.
Nutrients. 2018 Jun 29;10(7):849. doi: 10.3390/nu10070849.
Previously thought to be mainly a disorder of childhood and early adult life, coeliac disease (CeD) is increasingly diagnosed in older adults. This may be important given the association between CeD and osteoporosis. The primary aim of this study was to determine the seroprevalence of undiagnosed CeD (‘at-risk serology’) in an older Australian community and relate this to a diagnosis of osteoporosis and fractures during a follow-up period of 12 years. We included participants from the Hunter Community Study (2004⁻2007) aged 55⁻85, who had anti-tissue transglutaminase (tTG) titres, human leukocyte antigen (HLA) genotypes, and bone mineral density measurements at baseline. Follow-up data included subsequent diagnosis of CeD and fractures using hospital information. ‘At-risk’ serology was defined as both tTG and HLA positivity. Complete results were obtained from 2122 patients. The prevalence of ‘at-risk’ serology was 5%. At baseline, 3.4% fulfilled criteria for a diagnosis of osteoporosis. During a mean of 9.7 years of follow-up, 7.4% of the cohort suffered at least one fracture and 0.7% were subsequently diagnosed with CeD. At-risk serology was significantly associated with osteoporosis in a multivariate model (odds ratio 2.83, 95% confidence interval 1.29⁻6.22); there was insufficient power to look at the outcome of fractures. The results of this study demonstrate that at-risk CeD serology was significantly associated with concurrent osteoporosis but not future fractures. Most individuals with a serological diagnosis of CeD were not diagnosed with CeD during the follow-up period according to medical records. Coeliac disease likely remains under-diagnosed.
先前认为乳糜泻(CeD)主要是儿童和成年早期的疾病,但现在在老年人中越来越多地被诊断出来。鉴于 CeD 与骨质疏松症之间存在关联,这一点可能很重要。本研究的主要目的是确定在澳大利亚老年社区中未诊断的 CeD(“风险血清学”)的血清流行率,并将其与 12 年随访期间的骨质疏松症和骨折诊断相关联。我们纳入了 2004-2007 年亨特社区研究中年龄在 55-85 岁之间的参与者,他们在基线时具有抗组织转谷氨酰胺酶(tTG)滴度、人类白细胞抗原(HLA)基因型和骨密度测量值。随访数据包括使用医院信息随后诊断出的 CeD 和骨折。“风险”血清学定义为 tTG 和 HLA 均为阳性。从 2122 名患者中获得了完整的结果。“风险”血清学的患病率为 5%。在基线时,有 3.4%的患者符合骨质疏松症的诊断标准。在平均 9.7 年的随访期间,7.4%的队列患者至少遭受了一次骨折,0.7%的患者随后被诊断出患有 CeD。在多变量模型中,风险血清学与骨质疏松症显著相关(优势比 2.83,95%置信区间 1.29-6.22);没有足够的能力观察骨折的结果。本研究的结果表明,有风险的 CeD 血清学与同时存在的骨质疏松症显著相关,但与未来的骨折无关。根据医疗记录,在随访期间,大多数有 CeD 血清学诊断的患者并未被诊断出患有 CeD。乳糜泻可能仍然未被充分诊断。